Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 909-701-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3 mg/m³
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 8.33 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 120
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
Workers - Hazard for the eyes
Additional information - workers
The Derived No-Effect Levels (DNEL) were calculated using the recommendations of the ECHA "Guidance on information requirements and chemical safety assessment – Chapter R.8: Characterisation of dose [concentration]-response for human health" (May 2008).
The adverse effects selected for DNEL derivation were considered to bear a threshold mode of action.
The DNEL were not derived from NOAEL obtained in studies using the reaction mass of Cerium dioxide and Lanthanum oxide and Lanthanum fluoride but from the most conservative values obtained from studies performed on its majority main constituent, cerium dioxide. From the properties of the reaction mass of Cerium dioxide and Lanthanum oxide and Lanthanum fluoride, or its constituents, it is possible to attest that this approach is sufficiently conservative and in order to avoid unnecessary animals testing this approach will be followed for the derivation of the DNEL for the reaction mass of Cerium dioxide and Lanthanum oxide and Lanthanum fluoride.
- Acute toxicity:
In the absence of any relevant toxic effect and in particular any acute toxicity hazard leading to Classification & Labelling, no specific DNEL was derived.
- Irritation/Corrosion:
In the absence of irritation effects related to the test substance, no specific DNEL was derived.
- Sensitization:
In the absence of skin sensitization effects related to the test substance, no specific DNEL was derived.
- Repeat-dose toxicity:
Dermal exposure:
The study selected for dermal DNEL derivation is the OECD 422-compliant performed on cerium dioxide study in rats (CIT, 2010) where no significant systemic toxicity was observed up to the highest tested dose, i.e. 1000 mg/kg b.w./day.
- Dose descriptor: NOAEL = 1000 mg/kg bwin rats
- Corrected dose descriptor: No correction was applied (dermal NOAEL = oral NOAEL because both oral and dermal absorptions are considered negligible)
- Assessment factors:
Interspecies differences = 4 (default value for rats)
Other toxicokinetic differences = 1 (based on ECETOC and AGS recommendations)
Intraspecies differences = 5 (default value for workers)
Differences in exposure duration = 6 (default value for subacute to chronic exposure extrapolation)
Dose-response issues = 1 (use of a NOAEL as a starting point)
Quality of the database = 1 (complete and reliable data)
=> Global assessment factor = 120
- DNEL calculation:
Worker-DNEL long-term for dermal route, systemic effects = 1000 / 120 = 8.33mg/kg bw
Inhalation exposure:
The study that could have been used for inhalation DNEL derivation is the 90-day repeat-dose inhalation toxicity study in rats (BRL, 1994) performed on cerium dioxide. However, the effects that were observed in this study on the respiratory tract and lymphoreticular system following prolonged inhalatory exposure to poorly soluble particles can be considered as species-specific and bearing low relevance to the human situation (Ref. ILSI Risk Science Institute. The relevance of the rat lung response to particle overload for human risk assessment: A workshop consensus report. Inhalation Toxicology, 12: 1-17, 2000). Lung overload-related inflammatory response is commonly observed in rats following inhalation exposure to poorly soluble particles. The concept of overload applies specifically to poorly soluble particles with low cytotoxicity, such as cerium dioxide. The distribution of the retained particles within the lung compartments varies between species. It has been shown that during chronic inhalation exposure, particles are retained to a greater degree in interstitial locations in lungs of non-human primates and dogs than in lungs of rats, and that the interspecies differences in particle location might contribute to corresponding differences in tissue response (Ref. Snipes MB. Current information on lung overload in non-rodent mammals: contrast with rats. Inhalation Toxicology, 8(suppl): 91 -109, 1996). These differences combined with the fact that human macrophages have five times the volume of rat macrophages are considered to account for the tendency of rats to respond to poorly soluble particles with more chronic inflammation and epithelial responses compared to humans (Ref. Oberdörster G. Toxicokinetics and effects of fibrous and non-fibrous particles. Inhalation Toxicology, 14: 29-56, 2002).
Therefore the critical effect for DNEL derivation was deemed irrelevant to humans.
Different Occupational Exposure Levels are available in Europe: national and EU OEL on lanthanum fluoride range between 1 and 2.5 mg/m3. An occupational exposure level of 3 mg/m3 applicable to respirable dusts is used in most of the European countries. The specific OEL were not considered since the atoms of the different constituents of the reaction mass are embedded in the crystalline matrix and are therefore not likely to be released as such. In the absence of a fixed value on reaction mass of Cerium dioxide and Lanthanum oxide and Lanthanum fluoride, the unspecific OEL for respirable dusts was then applied to set a limit exposure value.
Worker-DNEL long-term for inhalation route, systemic effects = 3 mg/m3
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.5 mg/m³
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 4.17 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 240
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 4.17 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 240
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
General Population - Hazard for the eyes
Additional information - General Population
The Derived No-Effect Levels (DNEL) were calculated using the recommendations of the ECHA "Guidance on information requirements and chemical safety assessment – Chapter R.8: Characterisation of dose [concentration]-response for human health" (May 2008).
The adverse effects selected for DNEL derivation were considered to bear a threshold mode of action.
The DNEL were not derived from NOAEL obtained in studies using the reaction mass of Cerium dioxide and Lanthanum oxide and Lanthanum fluoride but from the most conservative values obtained from studies performed on its majority main constituent, cerium dioxide. From the properties of the reaction mass of Cerium dioxide and Lanthanum oxide and Lanthanum fluoride, or its constituents, it is possible to attest that this approach is sufficiently conservative and in order to avoid unnecessary animals testing this approach will be followed for the derivation of the DNEL for the reaction mass of Cerium dioxide and Lanthanum oxide and Lanthanum fluoride.
- Acute toxicity:
In the absence of any relevant toxic effect and in particular any acute toxicity hazard leading to Classification & Labelling, no specific DNEL was derived.
- Irritation/Corrosion:
In the absence of irritation effects related to the test substance, no specific DNEL was derived.
- Sensitization:
In the absence of skin sensitization effects related to the test substance, no specific DNEL was derived.
- Repeat-dose toxicity:
Dermal exposure:
The study selected for dermal DNEL derivation is the OECD 422-compliant performed on cerium dioxide study in rats (CIT, 2010) where no significant systemic toxicity was observed up to the highest tested dose, i.e. 1000 mg/kg b.w./day.
- Dose descriptor: NOAEL = 1000 mg/kg bwin rats
- Corrected dose descriptor: No correction was applied (dermal NOAEL = oral NOAEL because both oral and dermal absorptions are considered negligible)
- Assessment factors:
Interspecies differences = 4 (default value for rats)
Other toxicokinetic differences = 1 (based on ECETOC and AGS recommendations)
Intraspecies differences = 10 (default value for general population)
Differences in exposure duration = 6 (default value for subacute to chronic exposure extrapolation)
Dose-response issues = 1 (use of a NOAEL as a starting point)
Quality of the database = 1 (complete and reliable data)
=> Global assessment factor = 240
- DNEL calculation:
General population-DNEL long-term for dermal route, systemic effects = 1000 / 240 = 4.17mg/kg bw
Inhalation exposure:
The study that could have been used for inhalation DNEL derivation is the 90 -day repeat-dose inhalation toxicity study in rats (BRL, 1994). Similarly to the worker situation (see discussion above), the effects were considered as species-specific and not appropriate for DNEL derivation.
In order to set a limit exposure value, the unspecific Occupational Exposure Level of 3 mg/m3 applicable to respirable dusts and used in most of the European countries was considered, taking account of an additional assessment factor of 2 because of the default factors for intraspecies differences between workers (5) and general population (10).
General population-DNEL long-term for inhalation route, systemic effects = 3/2 = 1.5 mg/m3
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.